Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Newly emerging therapies targeting viral-related lymphomas.

Ramos JC, Lossos IS.

Curr Oncol Rep. 2011 Oct;13(5):416-26. doi: 10.1007/s11912-011-0186-8. Review.

2.

Viral lymphomagenesis.

Ahmed N, Heslop HE.

Curr Opin Hematol. 2006 Jul;13(4):254-9. Review.

PMID:
16755222
3.
4.

Hepatitis C virus and non-Hodgkin's lymphomas.

Pozzato G, Mazzaro C, Santini G, Burrone O.

Leuk Lymphoma. 1996 Jun;22(1-2):53-60. Review.

PMID:
8724528
5.

EBV-associated lymphoproliferative disorders: classification and treatment.

Carbone A, Gloghini A, Dotti G.

Oncologist. 2008 May;13(5):577-85. doi: 10.1634/theoncologist.2008-0036. Review.

6.

The association of the Epstein-Barr virus with malignant lymphoma.

Chang KL, Weiss LM.

Biomed Pharmacother. 1996;50(9):459-67. Review.

PMID:
8991118
7.

HIV infection and lymphoma.

Grogg KL, Miller RF, Dogan A.

J Clin Pathol. 2007 Dec;60(12):1365-72. Review.

8.

Blocking NF-kappaB as a potential strategy to treat adult T-cell leukemia/lymphoma.

Horie R, Watanabe T, Umezawa K.

Drug News Perspect. 2006 May;19(4):201-9. Review.

PMID:
16823495
9.

The contribution of the Epstein-Barr virus to the pathogenesis of childhood lymphomas.

Cader FZ, Kearns P, Young L, Murray P, Vockerodt M.

Cancer Treat Rev. 2010 Jun;36(4):348-53. doi: 10.1016/j.ctrv.2010.02.011. Epub 2010 Mar 2. Review.

PMID:
20193983
10.

Epstein-Barr virus: 40 years on.

Young LS, Rickinson AB.

Nat Rev Cancer. 2004 Oct;4(10):757-68. Review.

PMID:
15510157
11.

Microenvironmental abnormalities induced by viral cooperation: Impact on lymphomagenesis.

De Paoli P, Carbone A.

Semin Cancer Biol. 2015 Oct;34:70-80. doi: 10.1016/j.semcancer.2015.03.009. Epub 2015 Mar 30. Review.

12.
13.

HIV-associated lymphomas and gamma-herpesviruses.

Carbone A, Cesarman E, Spina M, Gloghini A, Schulz TF.

Blood. 2009 Feb 5;113(6):1213-24. doi: 10.1182/blood-2008-09-180315. Epub 2008 Oct 27. Review.

14.
15.

Human retroviruses: their role in cancer.

Blattner WA.

Proc Assoc Am Physicians. 1999 Nov-Dec;111(6):563-72. Review.

PMID:
10591085
16.

Interplay among viral antigens, cellular pathways and tumor microenvironment in the pathogenesis of EBV-driven lymphomas.

Dolcetti R, Dal Col J, Martorelli D, Carbone A, Klein E.

Semin Cancer Biol. 2013 Dec;23(6):441-56. doi: 10.1016/j.semcancer.2013.07.005. Epub 2013 Aug 3. Review.

PMID:
23917255
17.

Malignancies associated with epstein-barr virus: pathobiology, clinical features, and evolving treatments.

Neparidze N, Lacy J.

Clin Adv Hematol Oncol. 2014 Jun;12(6):358-71. Review.

PMID:
25003566
19.

Adoptive immunotherapy for Epstein-Barr virus-related lymphoma.

Smith CA, Ng CY, Loftin SK, Li C, Heslop HE, Brenner MK, Rooney CM.

Leuk Lymphoma. 1996 Oct;23(3-4):213-20. Review.

PMID:
9031101
20.

Recent Advances in Therapeutic Approaches for Adult T-cell Leukemia/Lymphoma.

Kato K, Akashi K.

Viruses. 2015 Dec 14;7(12):6604-12. doi: 10.3390/v7122960. Review.

Supplemental Content

Support Center